SynAct Pharma AB
| Position | Amount | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 2021-03-01 | SynAct Pharma AB | Henrik Stage | Chief Financial Officer (CFO) | Disposal | 22 725 | 50,464 | SEK | 1 146 793,8 | 2021-02-24 |
| 2021-03-01 | SynAct Pharma AB | Henrik Stage | Chief Financial Officer (CFO) | Disposal | 15 275 | 49,651 | SEK | 758 414,4 | 2021-02-25 |
| 2021-02-23 | SynAct Pharma AB | John Haurum | Member of the Board of Directors | Disposal | 5 968 | 55,085 | SEK | 328 749,667 | 2021-02-17 |
| 2021-01-11 | SynAct Pharma AB | Thomas Jonassen | Member of the Board of Directors, Other senior executive | Merger increase | 1 456 263 | 0 | SEK | 0 | 2021-01-05 |
| 2021-01-11 | SynAct Pharma AB | Thomas Jonassen | Member of the Board of Directors, Other senior executive | Merger increase | 2 296 651 | 0 | SEK | 0 | 2021-01-05 |
| 2021-01-11 | SynAct Pharma AB | Jeppe Øvli Øvlesen | Chief Executive Officer (CEO)/Managing Directory | Merger decrease | 1 456 263 | 0 | SEK | 0 | 2021-01-05 |
| 2021-01-11 | SynAct Pharma AB | Thomas Jonassen | Member of the Board of Directors, Other senior executive | Merger decrease | 2 296 651 | 0 | SEK | 0 | 2021-01-05 |
| 2020-07-23 | SynAct Pharma AB | Thomas Jonassen | Board of Director, Chief Strategy Officer / Styrelseledamot, CSO | Exercise decrease | 29 840 | 0 | SEK | 0 | 2020-07-21 |
| 2020-07-23 | SynAct Pharma AB | Thomas Jonassen | Board of Director, Chief Strategy Officer / Styrelseledamot, CSO | Exercise increase | 29 840 | 6,7 | SEK | 199 928 | 2020-07-21 |
| 2020-07-22 | SynAct Pharma AB | Torbjörn Bjerke | Chairman of the Board / Styrelseordförande | Exercise decrease | 29 840 | 0 | SEK | 0 | 2020-07-21 |
| 2020-07-22 | SynAct Pharma AB | Torbjörn Bjerke | Chairman of the Board / Styrelseordförande | Exercise increase | 29 840 | 6,7 | SEK | 199 928 | 2020-07-21 |
| 2020-07-22 | SynAct Pharma AB | Terje Kalland | Board of Director / Styrelseledamot | Exercise decrease | 29 840 | 0 | SEK | 0 | 2020-07-21 |
| 2020-07-22 | SynAct Pharma AB | Terje Kalland | Board of Director / Styrelseledamot | Exercise increase | 29 840 | 6,7 | SEK | 199 928 | 2020-07-21 |
| 2020-07-15 | SynAct Pharma AB | John Haurum | Board of Director / Styrelseledamot | Exercise decrease | 29 840 | 0 | SEK | 0 | 2020-07-08 |
| 2020-07-15 | SynAct Pharma AB | John Haurum | Board of Director / Styrelseledamot | Exercise increase | 29 840 | 6,7 | SEK | 199 928 | 2020-07-08 |
| 2020-07-14 | SynAct Pharma AB | Jeppe Øvlesen | CEO / Verkställande direktör | Exercise increase | 29 840 | 6,7 | SEK | 199 928 | 2020-07-09 |
| 2020-07-14 | SynAct Pharma AB | Jeppe Øvlesen | CEO / Verkställande direktör | Exercise decrease | 29 840 | 0 | SEK | 0 | 2020-07-09 |
| 2020-07-08 | SynAct Pharma AB | Henrik Stage | CFO | Exercise decrease | 29 840 | 0 | SEK | 0 | 2020-07-06 |
| 2020-07-08 | SynAct Pharma AB | Henrik Stage | CFO | Exercise increase | 29 840 | 6,7 | SEK | 199 928 | 2020-07-06 |
| 2020-03-23 | SynAct Pharma AB | Thomas Jonassen | Board of Director, Chief Strategy Officer/ Styrelseledamot, CSO | Gift given | 2 080 311 | 0 | SEK | 0 | 2019-11-26 |